TY - JOUR
T1 - Evaluation of Antiepileptic activity of Mosapride in Albino wistar rats
AU - Jain, Shubhika
AU - Chogtu, Bharti
AU - Krishna, Vybhava
AU - Khadke, Isha
N1 - Funding Information:
Authors are much obliged to the Dean and the administration of Kasturba Medical College, Manipal, Manipal Academy of Higher Education for supporting this project.
Publisher Copyright:
© RJPT All right reserved.
PY - 2021/12
Y1 - 2021/12
N2 - Serotonin causes a significant shift in the excitability of neurons and endogenous serotonin and drugs acting on serotonergic receptors play a role in pathogenesis of epilepsy. This study was done to study the effect of Mosapride, a serotonin receptor 5HT4 agonist, in animal models of epilepsy. Albino Wistar rats were divided into 5 groups with six animals in each group. Group 1 was control group, group 2 was standard group and group 3, 4 and 5 received test drug mosapride in low dose (3mg/kg), high dose (6mg/kg) and mosapride plus standard antiepileptic drug respectively. The antiepileptic efficacy was evaluated using Maximal Electroshock Seizure model (MES) and Pentylenetetrazole (PTZ) induced convulsions. Data was analysed using ANOVA followed by post hoc Tukeys test. Mosapride treated animals showed statistically significant decrease (p<0.001) in the duration of flexion, hind limb extension and post ictal depression in MES model which was comparable to phenytoin group. In PTZ model, mosapride alone did not show any significant difference as compared to control group in terms of latency and duration of seizures (p>0.05). The antiepileptic efficacy of mosapride is similar to phenytoin in MES model. However, in PTZ model mosapride did not show any beneficial antiepileptic effect.
AB - Serotonin causes a significant shift in the excitability of neurons and endogenous serotonin and drugs acting on serotonergic receptors play a role in pathogenesis of epilepsy. This study was done to study the effect of Mosapride, a serotonin receptor 5HT4 agonist, in animal models of epilepsy. Albino Wistar rats were divided into 5 groups with six animals in each group. Group 1 was control group, group 2 was standard group and group 3, 4 and 5 received test drug mosapride in low dose (3mg/kg), high dose (6mg/kg) and mosapride plus standard antiepileptic drug respectively. The antiepileptic efficacy was evaluated using Maximal Electroshock Seizure model (MES) and Pentylenetetrazole (PTZ) induced convulsions. Data was analysed using ANOVA followed by post hoc Tukeys test. Mosapride treated animals showed statistically significant decrease (p<0.001) in the duration of flexion, hind limb extension and post ictal depression in MES model which was comparable to phenytoin group. In PTZ model, mosapride alone did not show any significant difference as compared to control group in terms of latency and duration of seizures (p>0.05). The antiepileptic efficacy of mosapride is similar to phenytoin in MES model. However, in PTZ model mosapride did not show any beneficial antiepileptic effect.
UR - http://www.scopus.com/inward/record.url?scp=85123076228&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123076228&partnerID=8YFLogxK
U2 - 10.52711/0974-360X.2021.01100
DO - 10.52711/0974-360X.2021.01100
M3 - Article
AN - SCOPUS:85123076228
VL - 14
SP - 6364
EP - 6368
JO - Research Journal of Pharmacy and Technology
JF - Research Journal of Pharmacy and Technology
SN - 0974-3618
IS - 12
ER -